CL vs MCRB · P/E 34, rev $10.69B vs rev $1.1M
Colgate-Palmolive Company (CL) versus Seres Therapeutics Inc (MCRB) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Seres Therapeutics Inc (MCRB) is a biotechnology company listed on US.
Latest reported CL revenue for 2026-06-30 was $10.69B. Net income was $1.34B. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported MCRB revenue for 2026-06-30 was $1.1M. Net income was -$15.3M. MCRB currently screens at market cap $109.8M.
CL currently screens at market cap $70.88B and trailing P/E 34.3. MCRB currently screens at market cap $109.8M.
Not investment advice. Open the CL and MCRB stock pages for the full models.
Not investment advice.